Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders

被引:13
作者
Giannetti, Matthew P. [1 ,2 ]
Olivieri, Francesco [3 ]
Godwin, Grace [1 ]
Weller, Emma [1 ]
Nicoloro-SantaBarbara, Jennifer [2 ,4 ]
Bonadonna, Patrizia [3 ]
Zanotti, Roberta [5 ]
Zanoni, Giovanna [6 ]
Hartmann, Karin [7 ,8 ]
Castells, Mariana [1 ,2 ,8 ,9 ]
机构
[1] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 60 Fenwood Rd,Hale Bldg Transformat Med, Boston, MA 02132 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Verona Univ Hosp, Allergy Unit, Verona, Italy
[4] Brigham & Womens Boston, Dept Psychiat, Boston, MA USA
[5] Sect Hematol, Dept Med, Verona, Italy
[6] Verona Univ Hosp, Immunol Unit, Verona, Italy
[7] Univ Basel Hosp, Div Allergy, Basel, Switzerland
[8] Univ Basel, Basel, Switzerland
[9] Univ Basel Hosp, Dept Biomed, Basel, Switzerland
关键词
MASTOCYTOSIS;
D O I
10.1111/all.15476
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:301 / 304
页数:4
相关论文
共 7 条
[1]   Acute Allergic Reactions to mRNA COVID-19 Vaccines [J].
Blumenthal, Kimberly G. ;
Robinson, Lacey B. ;
Camargo, Carlos A., Jr. ;
Shenoy, Erica S. ;
Banerji, Aleena ;
Landman, Adam B. ;
Wickner, Paige .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15) :1562-1565
[2]   Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome [J].
Kaakati, Rayan ;
Khokhar, Dilawar ;
Akin, Cem .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (08) :3198-3199
[3]   Surveillance for Adverse Events After COVID-19 mRNA Vaccination [J].
Klein, Nicola P. ;
Lewis, Ned ;
Goddard, Kristin ;
Fireman, Bruce ;
Zerbo, Ousseny ;
Hanson, Kayla E. ;
Donahue, James G. ;
Kharbanda, Elyse O. ;
Naleway, Allison ;
Nelson, Jennifer Clark ;
Xu, Stan ;
Yih, W. Katherine ;
Glanz, Jason M. ;
Williams, Joshua T. B. ;
Hambidge, Simon J. ;
Lewin, Bruno J. ;
Shimabukuro, Tom T. ;
DeStefano, Frank ;
Weintraub, Eric S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14) :1390-1399
[4]   COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated [J].
Lazarinis, Nikolaos ;
Bossios, Apostolos ;
Gulen, Theo .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05) :1377-1379
[5]  
Rama TA., 2022, VACCINES-BASEL, V10, P1
[6]   mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis [J].
Rama, Tiago Azenha ;
Moreira, Andre ;
Castells, Mariana .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (03) :877-878
[7]   Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium [J].
Valent, Peter ;
Hartmann, Karin ;
Bonadonna, Patrizia ;
Gulen, Theo ;
Brockow, Knut ;
Alvarez-Twose, Ivan ;
Hermine, Olivier ;
Niedoszytko, Marek ;
Carter, Melody C. ;
Hoermann, Gregor ;
Butterfield, Joseph H. ;
Lyons, Jonathan J. ;
Sperr, Wolfgang R. ;
Greiner, Georg ;
Sotlar, Karl ;
Kluin-Nelemans, Hanneke C. ;
Schwaab, Juliana ;
Lange, Magdalena ;
George, Tracy, I ;
Siebenhaar, Frank ;
Broesby-Olsen, Sigurd ;
Jawhar, Mohamad ;
Nedoszytko, Boguslaw ;
Castells, Mariana ;
Orfao, Alberto ;
Gotlib, Jason ;
Reiter, Andreas ;
Horny, Hans-Peter ;
Triggiani, Massimo ;
Arock, Michel ;
Metcalfe, Dean D. ;
Akin, Cem .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (08) :1941-1950